Form 8-K - Current report:
SEC Accession No. 0001193125-25-005002
Filing Date
2025-01-13
Accepted
2025-01-13 08:02:02
Documents
40
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d904889d8k.htm   iXBRL 8-K 23863
2 EX-99.1 d904889dex991.htm EX-99.1 39937
6 GRAPHIC g904889ex99_1p10g1.jpg GRAPHIC 311128
7 GRAPHIC g904889ex99_1p11g1.jpg GRAPHIC 295439
8 GRAPHIC g904889ex99_1p12g1.jpg GRAPHIC 368451
9 GRAPHIC g904889ex99_1p13g1.jpg GRAPHIC 397372
10 GRAPHIC g904889ex99_1p14g1.jpg GRAPHIC 350159
11 GRAPHIC g904889ex99_1p15g1.jpg GRAPHIC 410467
12 GRAPHIC g904889ex99_1p16g1.jpg GRAPHIC 347599
13 GRAPHIC g904889ex99_1p17g1.jpg GRAPHIC 377235
14 GRAPHIC g904889ex99_1p18g1.jpg GRAPHIC 307062
15 GRAPHIC g904889ex99_1p19g1.jpg GRAPHIC 274526
16 GRAPHIC g904889ex99_1p1g1.jpg GRAPHIC 251427
17 GRAPHIC g904889ex99_1p20g1.jpg GRAPHIC 336625
18 GRAPHIC g904889ex99_1p21g1.jpg GRAPHIC 379750
19 GRAPHIC g904889ex99_1p22g1.jpg GRAPHIC 261576
20 GRAPHIC g904889ex99_1p23g1.jpg GRAPHIC 447962
21 GRAPHIC g904889ex99_1p24g1.jpg GRAPHIC 306680
22 GRAPHIC g904889ex99_1p25g1.jpg GRAPHIC 320584
23 GRAPHIC g904889ex99_1p26g1.jpg GRAPHIC 358844
24 GRAPHIC g904889ex99_1p2g1.jpg GRAPHIC 724837
25 GRAPHIC g904889ex99_1p3g1.jpg GRAPHIC 410806
26 GRAPHIC g904889ex99_1p4g1.jpg GRAPHIC 410484
27 GRAPHIC g904889ex99_1p5g1.jpg GRAPHIC 365406
28 GRAPHIC g904889ex99_1p6g1.jpg GRAPHIC 394606
29 GRAPHIC g904889ex99_1p7g1.jpg GRAPHIC 328051
30 GRAPHIC g904889ex99_1p8g1.jpg GRAPHIC 280963
31 GRAPHIC g904889ex99_1p9g1.jpg GRAPHIC 365831
  Complete submission text file 0001193125-25-005002.txt   13133382

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcax-20250113.xsd EX-101.SCH 2877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcax-20250113_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcax-20250113_pre.xml EX-101.PRE 11725
42 EXTRACTED XBRL INSTANCE DOCUMENT d904889d8k_htm.xml XML 3760
Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Filer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42271 | Film No.: 25524882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)